Last reviewed · How we verify

NCT05870176

ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors

ENROLLING BY INVITATION NA Last updated 4 November 2025
What this trial tests

NA trial testing Enhanced Referral in Cancer in 114 participants. Enrolling by invitation.

Timeline
11 September 2023
Primary endpoint
1 August 2026
1 November 2026

Quick facts

Lead sponsorUniversity of Massachusetts, Worcester
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposehealth services research
Enrollment114
Start date11 September 2023
Primary completion1 August 2026
Estimated completion1 November 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Massachusetts, Worcester

Who can join

Adults 18 to 110, any sex, with Cancer or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cardiovascular disease, the number one leading cause of death in the United States, is highly prevalent in cancer survivors. Physical activity can reduce risk, and referrals to programs addressing survivors' choices are highly recommended from providers in cancer survivorship, though rarely implemented. The study team proposes to develop ActivityChoice, a clinic-based implementation program, using patient narrative decision aids to support choices to a group in-person, group virtual, or self-monitored digital health physical activity program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other University of Massachusetts, Worcester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05870176.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing